5WA — OUE Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00- SG$97.75m
- SG$1.02bn
- SG$150.28m
- 12
- 92
- 37
- 45
Annual cashflow statement for OUE Healthcare, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -99.2 | 111 | 32.5 | 57.5 | 25.6 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 101 | -108 | 32.5 | 20.4 | 48.1 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.66 | -0.221 | -14.9 | -14.5 | -15.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.01 | 4.09 | 51.6 | 65.5 | 60.7 |
| Capital Expenditures | -1.37 | -0.954 | -0.61 | -0.477 | -0.605 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 8.11 | -29 | 43.8 | -62.4 | 19.3 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 6.74 | -30 | 43.2 | -62.8 | 18.7 |
| Financing Cash Flow Items | -2.91 | -3.11 | -66.2 | -61.1 | -59.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.79 | 2.03 | -67.9 | -8.09 | -68.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 16.3 | -25.1 | 23.1 | -7.26 | 10.3 |